pharma · Heart Valve Diseases · Angina, Stable
Beijing Anzhen Hospital
Beijing Anzhen Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Heart Valve Diseases, Angina, Stable. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 pat
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 1
- Patents
- 0
Corticosteroid
Unknown · small molecule · Heart Valve Diseases
Corticosteroid for Heart Valve Diseases is a Unknown program (small_molecule) at Beijing Anzhen Hospital with 1 ClinicalTrials.gov record(s).
Internal code 81070203
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing Anzhen Hospital
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Heart Valve Diseases
- Status
- completed
- Trials
- 1